Insulet Corp(PODD) Finding the best opportunities to buy and sell stocks daily.

Sector:

Healthcare

Description:

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. Its Omnipod System comprise two devices: a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, and its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, and the Middle East. Insulet Corporation was founded in 2000 and is headquartered in Acton, Massachusetts.

Current Price

$234.19

RSI

6.839

Beta:

0.640926

February 24, 2021
1.1B
-70.7M

17.090 %
13.922 %
-371.500 %
-42.228 %

$856,100,000
$695,500,000
$534,921,000
$463,768,000
$366,989,000
$324,225,000
23.091 %
30.019 %
15.342 %
26.371 %
13.190 %

$9,700,000
$14,500,000
$5,226,000
$-26,574,000
$-28,487,000
$-73,229,000
-49.485 %
177.459 %
608.496 %
7.199 %
157.061 %

News

Press Releases

Notable Dates

All stock recommendations and comments are all opinions. Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.